Clinical management and mortality among COVID-19 cases in sub-Saharan Africa: A retrospective study from Burkina Faso and simulated case analysis

Laura Skrip(London School of Hygiene & Tropical Medicine), André Lin Ouédraogo(Bellevue Hospital Center), Bicaba W. Brice, Halidou Tinto(Institut de Recherche en Sciences de la Santé), Karim Derra(Institut de Recherche en Sciences de la Santé), Brittany Hagedorn(Gates Foundation), Mikaïla Kaboré(Centre Hospitalier Universitaire Yalgado Ouédraogo), Mollie M. Van Gordon(Bellevue Hospital Center), Hervé Hien(Centre Muraz), Benjamin M. Althouse, Innocent Valéa(Institut de Recherche en Sciences de la Santé), Edward A. Wenger(Gates Foundation), Adama Gansané(Centre National de Recherche et de Formation sur le Paludisme)
International Journal of Infectious Diseases
September 26, 2020
10.1016/j.ijid.2020.09.1432
Cited by 31

Related Papers

Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet|2017|2.2k
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial
|The Lancet|2021|457
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine
|New England Journal of Medicine|2015|451
HIV Treatment as Prevention: Systematic Comparison of Mathematical Models of the Potential Impact of Antiretroviral Therapy on HIV Incidence in South Africa
|PLoS Medicine|2012|406
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial
|The Lancet|2024|345